to have particular expectations of assays and then to rely on the publication of individual assays to bring up shareprice is nothing more than a day-trading dream.

if the market was 'valuating' GNH correctly, then all PP holders of the previous .15 cents and the upcoming .25 cents strike points would have (had) no worries in exercising.

the market however is very often wrong ...as warren buffet knows so intimately well :))

if the market does not like the up coming assays because they are not "spectacular" enough then the share price may retreat ...i don't think this will be the case because most investors realize the value of such assays in their primary role ...expanding our already undervalued deposit.

but... there are those who promote the concept of waiting for assays for the purpose of shareprice movement and possible short term profits ...if this group has prominance, then when assays come out, you can be assured our share price will plumit, as they wait to sell on those assays.

as well... the junior market as whole has been down beyond reason for some time ...people forget this overall powerful factor, as they come up with varied reasoning as to our fall from 90 cents. this depreciation is caused primarly by the junior market sentiment: ...just have a look at the average junior chart over the past 2 years.

gnh is a long term investment

cheers danny